SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-15-000236
Filing Date
2015-02-17
Accepted
2015-02-17 12:09:01
Documents
1
Group Members
DEERFIELD INTERNATIONAL MASTER FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 e613326_sc13ga-optimer.htm SC 13G/A 235100
  Complete submission text file 0001193805-15-000236.txt   236531
Mailing Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET SUITE 3501 JERSEY CITY NJ 07302 (201) 333-8819
OPTIMER PHARMACEUTICALS INC (Subject) CIK: 0001142576 (see all company filings)

IRS No.: 330830300 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82752 | Film No.: 15619795
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A